Induction of Labor Affected Fetus / Newborn
Conditions
Brief summary
To compare propranolol and misoprostol versus misoprostol alone for induction of labour in primigravidas
Detailed description
Candidates will be randomized into 2 groups according to a computer generated sequence. Each candidate will be assigned an opaque sealed envelope containing a paper with her group on it. Both the patient and doctor on duty will be blinded to which group the patient was assigned to. \- Study procedure: 1. Written informed consent will be obtained from all participants prior to the study. 2. Full history taking. 3. General examination. Patients will be subjected to the following: * Patients attending labour room for induction of labour will be divided into two groups. * Both groups, women are induced with Tab misoprostol 25μg applied to posterior vaginal fornix under aseptic precaution and every 6 hours for a maximum of 4 doses. * In group 1, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral Propanolol 20mg * In group 2, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral placebo in the form of sugary tablets. * After induction, women will be monitored for fetal and maternal wellbeing and progress of labour.
Interventions
Pt will receive misoprostol for labor induction then after 30 minutes will receive ether propranolol or misoprostol
placebo
Propranolol
Sponsors
Study design
Masking description
Double blinded research
Intervention model description
Clinical trial
Eligibility
Inclusion criteria
* • Primigravidas. * Full term patients with ultrasound confirmed dates. * Singleton. * Cephalic presentation. * Fetal heart rate between 120 to 160 beats per minute.
Exclusion criteria
* • Any history of previous surgery on the uterus. * Patients in active labour, with ruptured membranes. * Fetal distress. * Macrosomia or polyhydramnios * Hypersensitivity to prostaglandins. * Asthmatic patient . * liver or kidney impairment . * known cardiac patient with abnormal ECG.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Induction delivery interval | procedure delivery | The time from starting induction to the delivery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mode of delivery | delivery | Vaginal delivery or cesarian section |
Countries
Egypt